Ambalal Sarabhai Enterprises Ltd - 500009 - Declaration On Unmodified Opinion
Declaration On Unmodified Opinion on the Audited Financial Statements for financial year ended March 31, 202105-06-2021
05-06-2021
AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Financial Results For The Quarter & Financial Year Ended On 31/03/2021
We are hereby enclosing the Audited Financial Results of the Company for the Quarter & Financial Year ended on 31/03/202104-06-2021
AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Outcome Of Board Meeting Held On 4Th June, 2021
We wish to inform you that following matters have been discussed, considered and approved by the Board of Directors in its meeting held on 4th June, 2021: 1. The Board has considered, approved and taken on record the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended on 31st March, 2021 along with Auditors Report thereon, in pursuant to Regulations 30 & 33 of SEBI SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. 2. Re-appointed M/s. Gautam Joshi & Co., Chartered Accountant, (FRN: 130037W) as internal Auditor of the Company for the financial year 2021-2022. 3. Appointed RPAP & Co., Company Secretaries, Ahmedabad (COP No.: 2939, Membership No.: A8073) as Secretarial Auditors of the Company for the financial year 2021-22.04-06-2021
Ambalal Sarabhai Enterprises Ltd - 500009 - Outcome Of Board Meeting Held On 4Th June, 2021
We wish to inform you that following matters have been discussed, considered and approved by the Board of Directors in its meeting held on 4th June, 2021: 1. The Board has considered, approved and taken on record the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended on 31st March, 2021 along with Auditors Report thereon, in pursuant to Regulations 30 & 33 of SEBI SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. 2. Re-appointed M/s. Gautam Joshi & Co., Chartered Accountant, (FRN: 130037W) as internal Auditor of the Company for the financial year 2021-2022. 3. Appointed RPAP & Co., Company Secretaries, Ahmedabad (COP No.: 2939, Membership No.: A8073) as Secretarial Auditors of the Company for the financial year 2021-22.04-06-2021
AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter & Financial Year Ended On March 31, 2021
AMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the exchange that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, June 4, 2021, inter-alia, to transact the following: 1. To consider and approve the Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2021. 2. Any other matter as the Board of Directors of the Company may decide during the course of the meeting.28-05-2021
AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Caplin Viniyog Pvt Ltd22-05-2021
AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Caplin Viniyog Pvt Ltd20-05-2021
AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Announcement Under Regulation 30 Of LODR - Updates
Synbiotics Limited, a subsidiary of ASE is the only manufacturer of the Active Pharmaceutical Ingredient (API) Amphotericin B in India and looking at the current outbreak of MUCORMYCOSIS and expected requirement, Synbiotics has ramped up the manufacturing capacity to meet the requirement of this most effective anti-fungal Antibiotic in the post Covid crisis. The detailed announcement has been enclosed for your reference.11-05-2021
Ambalal Sarabhai Enterprises Ltd - 500009 - Announcement Under Regulation 30 Of LODR - Updates
CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited, recognized for Work Combating COVID-19 Surge in India. The detailed announcement has been enclosed for your reference.03-05-2021
Ambalal Sarabhai Enterprises Ltd - 500009 - Annual Disclosure Regarding Non Applicability Of SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated Nov 26,2018
Pursuant to the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 with respect to fund raising by issuance of Debt Securities by Large Entities, we wish to state that for the financial year ended March 31, 2021, the Company is not a ''''Large Corporate'''' as per the framework and applicability criteria provided in the aforesaid Circular.30-04-2021